Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Candidate Biomarkers in Giant Cell Tumors of Bone.
Conti A, Luchini A, Benassi MS, Magagnoli G, Pierini M, Piccinni-Leopardi M, Quattrini I, Pollino S, Picci P, Liotta LA, Pazzaglia L. Conti A, et al. Among authors: pierini m. Proteomics Clin Appl. 2018 Nov;12(6):e1800041. doi: 10.1002/prca.201800041. Epub 2018 Aug 28. Proteomics Clin Appl. 2018. PMID: 30054970
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP. Palmerini E, et al. Among authors: pierini m. Eur J Cancer. 2017 May;76:118-124. doi: 10.1016/j.ejca.2017.01.028. Epub 2017 Mar 17. Eur J Cancer. 2017. PMID: 28324746
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
Palmerini E, Ruggieri P, Angelini A, Boriani S, Campanacci D, Milano GM, Cesari M, Paioli A, Longhi A, Abate ME, Scoccianti G, Terzi S, Trovarelli G, Franchi A, Picci P, Ferrari S, Leopardi MP, Pierini M. Palmerini E, et al. Among authors: pierini m. Tumori. 2018 Oct;104(5):344-351. doi: 10.1177/0300891618784808. Epub 2018 Aug 8. Tumori. 2018. PMID: 30086700 Free PMC article.
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.
Palmerini E, Pazzaglia L, Cevolani L, Pratelli L, Pierini M, Quattrini I, Carretta E, Manara MC, Pasello M, Frega G, Paioli A, Longhi A, Cesari M, Hakim R, Ibrahim T, Campanacci L, Staals EL, Donati DM, Benassi MS, Scotlandi K, Ferrari S. Palmerini E, et al. Among authors: pierini m. Cancers (Basel). 2022 Jun 10;14(12):2863. doi: 10.3390/cancers14122863. Cancers (Basel). 2022. PMID: 35740530 Free PMC article.
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E, Torricelli E, Cascinu S, Pierini M, De Paolis M, Donati D, Cesari M, Longhi A, Abate M, Paioli A, Setola E, Ferrari S. Palmerini E, et al. Among authors: pierini m. Pediatr Blood Cancer. 2019 Aug;66(8):e27792. doi: 10.1002/pbc.27792. Epub 2019 May 6. Pediatr Blood Cancer. 2019. PMID: 31058424
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E. Boye K, et al. Among authors: pierini m. Cancer Immunol Immunother. 2021 Sep;70(9):2617-2624. doi: 10.1007/s00262-021-02876-w. Epub 2021 Feb 12. Cancer Immunol Immunother. 2021. PMID: 33580363 Free PMC article. Clinical Trial.
594 results